Literature DB >> 12023174

Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome.

A R Gennery1, D Barge, J J O'Sullivan, T J Flood, M Abinun, A J Cant.   

Abstract

BACKGROUND: Although severe T cell immunodeficiency in DiGeorge anomaly is rare, previous studies of humoral function in these patients have found no antibody abnormalities but have not examined the response to polysaccharide antigens. Isolated cases of autoimmunity have been reported. Several patients with 22q11.2 deletion attending our immunology clinic suffered recurrent sinopulmonary infection or autoimmune phenomena. AIMS: To investigate humoral immunodeficiency, particularly pneumococcal polysaccharide antibody deficiency, and autoimmune phenomena in a cohort of patients with 22q11.2 deletion.
METHODS: A history of severe or recurrent infection and autoimmune symptoms were noted. Lymphocyte subsets, immunoglobulins, IgG subclasses, specific vaccine antibodies, and autoantibodies were measured. Subjects were vaccinated with appropriate antigens as indicated.
RESULTS: Of 32 patients identified, 26 (81%) had severe or recurrent infection, of which 13 (50%) had abnormal serum immunoglobulin measurements and 11/20 >/=4 years old (55%) had an abnormal response to pneumococcal polysaccharide. Ten of 30 patients (33%) had autoimmune phenomena; six (20%) were symptomatic.
CONCLUSIONS: Humoral immunodeficiency is more common than previously recognised in patients with 22q11.2 deletion. Normal T cell function and immunoglobulin levels do not exclude poor specific antibody responses. Patients should be referred for formal immunological assessment of cellular and humoral immune function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023174      PMCID: PMC1763000          DOI: 10.1136/adc.86.6.422

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  The amplifier role of T cells in the human in vitro B cell response to type 4 pneumococcal polysaccharide.

Authors:  A W Griffioen; E A Toebes; G T Rijkers; F H Claas; G Datema; B J Zegers
Journal:  Immunol Lett       Date:  1992-05       Impact factor: 3.685

Review 2.  Developmental and maturational changes in human blood lymphocyte subpopulations.

Authors:  I Hannet; F Erkeller-Yuksel; P Lydyard; V Deneys; M DeBruyère
Journal:  Immunol Today       Date:  1992-06

3.  Decreases in CD5+ B lymphocytes in children with the DiGeorge anomaly.

Authors:  A P Kourtis; C C Ibegbu; F K Lee; L Vogler; K Philips; A J Nahmias
Journal:  Scand J Immunol       Date:  1997-09       Impact factor: 3.487

4.  DiGeorge anomaly: a comparative study of the clinical and immunologic characteristics of patients positive and negative by fluorescence in situ hybridization.

Authors:  S J Kornfeld; B Zeffren; C S Christodoulou; N K Day; G Cawkwell; R A Good
Journal:  J Allergy Clin Immunol       Date:  2000-05       Impact factor: 10.793

5.  Autoimmune phenomena in DiGeorge syndrome.

Authors:  A Etzioni; S Pollack
Journal:  Isr J Med Sci       Date:  1994-11

6.  The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  H Käyhty; H Peltola; V Karanko; P H Mäkelä
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

7.  Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome).

Authors:  K E Sullivan; D M McDonald-McGinn; D A Driscoll; C M Zmijewski; A S Ellabban; L Reed; B S Emanuel; E H Zackai; B H Athreya; G Keenan
Journal:  Arthritis Rheum       Date:  1997-03

8.  Selective polysaccharide antibody deficiency in familial DiGeorge syndrome.

Authors:  M S Schubert; R B Moss
Journal:  Ann Allergy       Date:  1992-09

9.  Predictors of infection in chronic lymphocytic leukaemia (CLL).

Authors:  H Griffiths; J Lea; C Bunch; M Lee; H Chapel
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

10.  Humoral immunity in DiGeorge syndrome.

Authors:  A K Junker; D A Driscoll
Journal:  J Pediatr       Date:  1995-08       Impact factor: 4.406

View more
  38 in total

Review 1.  New frontiers in primary immunodeficiency disorders: immunology and beyond….

Authors:  Eleonora Gambineri
Journal:  Cell Mol Life Sci       Date:  2011-10-19       Impact factor: 9.261

2.  Immunologic reconstitution in 22q deletion (DiGeorge) syndrome.

Authors:  Sean A McGhee; Maria Garcia Lloret; E Richard Stiehm
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

3.  Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  R Zemble; E Luning Prak; K McDonald; D McDonald-McGinn; E Zackai; K Sullivan
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

4.  A 13-Year-Old Child with Lupus-Like Nephritis and 22q11 Microduplication Syndrome.

Authors:  Zoi Dorothea Pana; Maria Stamou; Ioannis Kalevrosoglou; Ioannis Kyriakidis; Maria Hatzistilianou
Journal:  J Clin Immunol       Date:  2016-11-04       Impact factor: 8.317

5.  Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome.

Authors:  Yiwa Suksawat; Achara Sathienkijkanchai; Jittima Veskitkul; Orathai Jirapongsananuruk; Nualanong Visitsunthorn; Pakit Vichyanond; Punchama Pacharn
Journal:  J Clin Immunol       Date:  2017-04-20       Impact factor: 8.317

Review 6.  Immunological aspects of 22q11.2 deletion syndrome.

Authors:  A R Gennery
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

Review 7.  CHARGE syndrome: a review of the immunological aspects.

Authors:  Monica T Y Wong; Elisabeth H Schölvinck; Annechien J A Lambeck; Conny M A van Ravenswaaij-Arts
Journal:  Eur J Hum Genet       Date:  2015-02-18       Impact factor: 4.246

8.  Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors.

Authors:  B L Ferry; S A Misbah; P Stephens; Z Sherrell; H Lythgoe; E Bateman; C Banner; J Jones; N Groome; H M Chapel
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

9.  Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome.

Authors:  P Eberle; C Berger; S Junge; S Dougoud; E Valsangiacomo Büchel; M Riegel; A Schinzel; R Seger; T Güngör
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

Review 10.  Autoimmunity in immunodeficiency.

Authors:  Krista Todoric; Jessica B Koontz; Daniel Mattox; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.